Trubridge Inc (OQ:TBRG)
Business Focus: Medical Software & Technology Services
| Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 54 St. Emanuel Street MOBILE AL 36602 |
| Tel: | N/A |
| Website: | https://trubridge.com |
| IR: | See website |
| Key People | ||
| Christopher L. Fowler President, Chief Executive Officer, Director | Vinay Bassi Chief Financial Officer, Treasurer, Company Secretary | David A. Dye Chief Operating Officer, Director |
| Wes D. Cronkite Chief Technology and Innovation Officer | Kevin Plessner General Counsel | Dawn M. Severance Chief Sales Officer |
| Business Overview |
| TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company operates through three segments: RCM, HER and Patient Engagement. The RCM segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics and business intelligence. The EHR segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Engagement segment offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its wholly owned subsidiaries include Viewgol, LLC, iNetXperts, Corp. doing business as Get Real Health, Healthcare Resource Group, Inc. and Healthland Holding Inc. |
| Financial Overview |
| For the three months ended 31 March 2024, Trubridge Inc revenues decreased 3% to $83.2M. Net loss applicable to common stockholders totaled $2.4M vs. income of $3M. Revenues reflect EHR segment decrease of 20% to $28M, Patient engagement segment decrease of 9% to $2.2M. Net loss reflects General and administrative increase of 30% to $19.4M (expense), Interest Expense increase of 53% to $4.1M (expense). |
| Employees: | 3,219 as of Dec 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $319.51M as of Mar 31, 2024 |
| Annual revenue (TTM): | $336.45M as of Mar 31, 2024 |
| EBITDA (TTM): | $39.56M as of Mar 31, 2024 |
| Net annual income (TTM): | -$50.22M as of Mar 31, 2024 |
| Free cash flow (TTM): | -$32.66M as of Mar 31, 2024 |
| Net Debt Last Fiscal Year: | $180.69M as of Mar 31, 2024 |
| Shares outstanding: | 15,007,262 as of May 8, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.